Treatment of pancreatic cancer largely depends on the age of the person and the tumor location,” says the Co-Chairman

As it is with most forms of cancer, early detection is essential for a positive outcome,” says Dr. Echt.

Pancreatic cancer’s current 5-year survival rate of less than 10 percent is attributed to a number of factors. This disease, for example, has no routine screening like breast cancer or prostate.

The blood test under development seeks out a pair of markers that people with pancreatic cancer display in their blood.

According to the American Cancer Society, pancreatic cancer survival rates range between 12 and 14 percent when the cancer is detected in early stages.

Radiotherapy has been deemed largely ineffective in the treatment of pancreatic cancer in many previous studies. As the researchers pointed out, however, previous studies relied on dosing in the

Pancreatic cancer tumors, often diagnosed in later stages, are known to be very resistant to chemotherapy drugs and other treatments.

Pancreatic cancer is estimated to impact about 53,000 Americans each year. The disease is responsible for about 43,000 deaths.

The study in question found very promising results, especially in connection with non-metastatic cancers.

Like many forms of cancer, pancreatic cancer is most successfully treated in its earliest stages. This form of cancer, however, presents with few, if any, symptoms at its onset.

Pancreatic cancer strikes an estimated 53,000 men and women in the United States each year.

Pancreatic cancer is one of the deadliest forms of this disease. Presenting at first with very few, if any, symptoms, this cancer often goes undetected until its more advanced stages.

Neoadjuvant therapy involves the use of interventions that are prescribed prior to surgery. They may include such measures as chemotherapy, radiation or a combination of the two.